GlassScriptPhysician profile
Jodanne W Hedrick
NPI 1730263948
$1,407.33
in general payments reported to CMS, 2019-2025
24 companies · $401 in 2025
The $401 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $134 · 2021: $208 · 2022: $101 · 2023: $139 · 2024: $226 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $765.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $285.90 | 2019-2024 | |
| Astellas Pharma US INC | $237.21 | 2024-2025 | Veozah |
| Sumitomo Pharma America, INC. | $169.21 | 2023-2024 | Myfembree |
| Mayne Pharma Commercial LLC | $86.10 | 2025 | |
| Allergan, INC. | $61.98 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.63 | 2021-2022 | |
| Pfizer INC. | $46.64 | 2023-2025 | |
| Medtronic, INC. | $45.04 | 2022-2025 | Truclear |
| Mallinckrodt Enterprises LLC | $43.25 | 2019 | |
| Biogen, INC. | $42.51 | 2024 | |
| Therapeuticsmd, INC. | $38.77 | 2019-2020 | |
| Novo Nordisk INC | $37.36 | 2019-2022 | |
| Coopersurgical, INC. | $37.02 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Dysis Medical, INC. | $35.99 | 2021 | |
| Hologic Sales and Service, LLC | $28.09 | 2021-2024 | Myosure Tissue Removal Device, Novasure |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $24.54 | 2020 | |
| Daiichi Sankyo INC. | $24.25 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $20.67 | 2025 | |
| Lilly USA, LLC | $20.12 | 2025 | Zepbound |
| Emd Serono, INC. | $19.98 | 2019 | |
| Exeltis, USA INC. | $14.45 | 2024 | Slynd |
| Axonics, INC. | $13.61 | 2022 | |
| Myovant Sciences INC. | $12.36 | 2021 | |
| Eisai INC. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jodanne Hedrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.